The Boehringer Ingelheim Group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 143 affiliates and a total of more than 45,600 employees in 2016. The focus of the family-owned company, founded in 1885, is researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.
Social responsibility is an important element of the corporate culture at Boehringer Ingelheim. This includes worldwide involvement in social projects, such as the initiative “Making More Health” and caring for the employees. Respect, equal opportunities and reconciliation of work and family life form the foundation of the mutual cooperation. In everything it does, the company focuses on environmental protection and sustainability.
|Amounts in millions of EUR,
unless otherwise indicated
|Asia, Australia, Africa||27%||25%|
|Consumer Health Care||10%||10%|
|Industrial Customers and other sales||1%||1%|
|Research and development||3,112||3,004||+4%|
|Average number of employees||45,692||47,501||–4%|
|Operating income as % of net sales||18.1%||15.3%|
|as % of net sales||11.7%||10.7%|
|Return on Group equity||19.3%||19.4%|
|Investments in tangible assets||645||591||+9%|
|Depreciation of tangible assets||516||475||+9%|